The Securities and Exchange Commission requires wealthy stock traders to disclose their transactions every three months. Citadel sold Palantir shares but invested in Summit Therapeutics, a clinical-stage cancer drug developer with promising results, indicating potential growth.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing